World-First Trial to Test Whether Alzheimer’s Drug Can Delay or Prevent Disease
6 Articles
6 Articles
Scientists will check whether the experimental trontinemab drug is capable of preventing dementia from developing in people who do not have memory problems yet, but have biomarks for high risk Alzheimer's disease.
The Independent
The Independent (US)World-first trial to test whether Alzheimer’s drug can delay or prevent disease
A large international clinical study will test a new strategy against Alzheimer's disease: the intervention before memory begins to deteriorate. Approximately 1,600 people aged 55 to 80 years, without symptoms, will be evaluated from the beginning of...
In a UK National Health Service (NHS) trial, unprecedented in Europe, people at high risk of Alzheimer's disease but showing no symptoms will be given an Alzheimer's drug. The trial will investigate whether Alzheimer's disease can be delayed or prevented. For this purpose, people at high risk for the disease will be given Trontinemab. Read more This section contains reference points related to the topic. (Related Nodes field) According to BBC …
The trial's interest lies in the fact that participants will not have memory problems or other obvious symptoms of Alzheimer's. Can Alzheimer's disease be treated before memory problems even appear? A new international clinical trial is attempting to answer this question, in which an experimental drug will be administered to people who do not show symptoms of dementia, but are considered to be at increased risk of developing the disease in the f…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
